Ernexa Therapeutics Inc. (ERNA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.84M
Last updated: Nov 17, 2026 at 11:04 AM ET
Ernexa Therapeutics Inc. (ERNA) Competitors
The companies most similar to Ernexa Therapeutics are Imunon (IMNN), Revelation Biosciences (REVB) and Calidi Biotherapeutics (CLDI). By market cap, Ernexa Therapeutics ranks 8th of the 13 companies on this page; Imunon (IMNN) is the largest at $4.08M.
Peer Comparison
ERNA's revenue growth of -94.1% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Ernexa Therapeutics (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Purple Biotech (PPBT) | $2.65M | N/A | N/A | 0.0% | -156.2% | 0.0% | 0.00% |
| BioRestorative Therapies Inc (BRTX) | $2.06M | N/A | 70.3x | 0.0% | -289.9% | -7.3% | 0.00% |
| Bioatla Inc (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | $3.93M | N/A | 4.0x | 0.0% | N/A | 0.0% | 0.00% |
| GRI Bio Inc. (GRI) | $3.72M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Traws Pharma Inc (TRAW) | $3.86M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Enlivex Therapeutics Ltd (ENLV) | $1.82M | N/A | N/A | 0.0% | -0.3% | 0.0% | 0.00% |
| Peer median | $2.93M | N/A | 4.0x | 0.0% | -143.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Ernexa Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Purple Biotech (PPBT) | Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United... | PPBT competitors |
| BioRestorative Therapies Inc (BRTX) | BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue... | BRTX competitors |
| Bioatla Inc (BCAB) | BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. | BCAB competitors |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment... | |
| GRI Bio Inc. (GRI) | GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology. | GRI competitors |
| Traws Pharma Inc (TRAW) | Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. | TRAW competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| Enlivex Therapeutics Ltd (ENLV) | Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel. | ENLV competitors |
Frequently Asked Questions About ERNA
Who are Ernexa Therapeutics' main competitors?
The companies most similar to Ernexa Therapeutics include Imunon (IMNN), Revelation Biosciences (REVB), Calidi Biotherapeutics (CLDI), PharmaCyte Biotech (PMCB) and Purple Biotech (PPBT), listed from the closest match.
Who is Ernexa Therapeutics' biggest competitor?
Imunon (IMNN) is both the largest of the similar companies at $4.08M and the closest match by business profile, size, sector and industry.
How does ERNA stock compare with its competitors?
ERNA's net margin is 0.0% against a peer median of 0.0%.
Which of Ernexa Therapeutics' competitors pays a higher dividend?
Ernexa Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Ernexa Therapeutics bigger than its competitors?
No. Ernexa Therapeutics is 8th by market cap among the 13 companies on this page; the largest is Imunon (IMNN) at $4.08M.
ERNA pages: Overview, Earnings, Forecast, Financials, Competitors